English  |  正體中文  |  简体中文  |  2823024  
???header.visitor??? :  30210748    ???header.onlineuser??? :  855
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"soo r a"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 51-56 of 56  (3 Page(s) Totally)
<< < 1 2 3 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-05-25T07:35:07Z Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study Solomon B.J; Shaw A.T.; Ignatius Ou S.-H; Thurm H; Peltz G; Besse B; Bauer T.M; Felip E; Soo R.A; Camidge D.R; Chiari R; Bearz A; Chia-Chi Lin; Gadgeel S.M; Riely G.J; Tan E.H; Seto T; James L.P; Clancy J.S; Abbattista A; Martini J.-F; Chen J
臺大學術典藏 2020-05-25T07:34:59Z Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer Peters S; Shaw A.T; Besse B; Felip E; Solomon B.J; Soo R.A; Bearz A; Gadgeel S.M; Chia-Chi Lin; Kao S; Seto T; Masters E.T; Abbattista A; Clancy J.S; Thurm H; Reisman A; Peltz G; Ross Camidge D.
臺大學術典藏 2020 Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC Yang F.; Tan D.S.W; Mok T.S.K; Ahn M.-J; Onishi H; Ahn Y.C; Soo R.A; Kim D.-W; Yang J.C; Reungwetwattana T; Ho G.F; Yang F.;Tan D.S.W;Mok T.S.K;Ahn M.-J;Onishi H;Ahn Y.C;Soo R.A;Kim D.-W;Yang J.C;Reungwetwattana T;Ho G.F;Chan A.W;Tho L.M;Lee V.H.F;Chia-Chi Lin;Chua K.L.M;Tan W.L; Tan W.L; Chua K.L.M; Chia-Chi Lin; Lee V.H.F; Tho L.M; Chan A.W
臺大學術典藏 2020 Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC Yang F.; Tan D.S.W; Mok T.S.K; Ahn M.-J; Onishi H; Ahn Y.C; Soo R.A; Kim D.-W; Yang J.C; Reungwetwattana T; Ho G.F; Yang F.;Tan D.S.W;Mok T.S.K;Ahn M.-J;Onishi H;Ahn Y.C;Soo R.A;Kim D.-W;Yang J.C;Reungwetwattana T;Ho G.F;Chan A.W;Tho L.M;Lee V.H.F;Chia-Chi Lin;Chua K.L.M;Tan W.L; Tan W.L; Chua K.L.M; Chia-Chi Lin; Lee V.H.F; Tho L.M; Chan A.W
臺大學術典藏 2019 Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1�V2 trial Ou S.-H.I.;Li S;Abbattista A;Peltz G;Martini J.-F;Thurm H;Clancy J.S;Bauer T.M;Chia-Chi Lin;Kao S;Soo R.A;Besse B;Riely G.J;Chiari R;Solomon B.J;Shaw A.T; Shaw A.T; Solomon B.J; Chiari R; Riely G.J; Besse B; Soo R.A; Kao S; Chia-Chi Lin; Bauer T.M; Clancy J.S; Thurm H; Martini J.-F; Peltz G; Abbattista A; Li S; Ou S.-H.I.
臺大學術典藏 2019 Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1�V2 trial Ou S.-H.I.;Li S;Abbattista A;Peltz G;Martini J.-F;Thurm H;Clancy J.S;Bauer T.M;Chia-Chi Lin;Kao S;Soo R.A;Besse B;Riely G.J;Chiari R;Solomon B.J;Shaw A.T; Shaw A.T; Solomon B.J; Chiari R; Riely G.J; Besse B; Soo R.A; Kao S; Chia-Chi Lin; Bauer T.M; Clancy J.S; Thurm H; Martini J.-F; Peltz G; Abbattista A; Li S; Ou S.-H.I.

Showing items 51-56 of 56  (3 Page(s) Totally)
<< < 1 2 3 
View [10|25|50] records per page